Literature DB >> 25911551

Pbx3 and Meis1 cooperate through multiple mechanisms to support Hox-induced murine leukemia.

Maria-Paz Garcia-Cuellar1, Julia Steger1, Elisa Füller1, Katrin Hetzner1, Robert K Slany2.   

Abstract

Hox homeobox transcription factors drive leukemogenesis efficiently only in the presence of Meis or Pbx proteins. Here we show that Pbx3 and Meis1 need to dimerize to support Hox-induced leukemia and we analyze the molecular details of this cooperation. In the absence of Pbx3, Meis1 was highly unstable. As shown by a deletion analysis Meis1 degradation was contingent on a motif coinciding with the Pbx-binding domain. Either deletion of this sequence or binding to Pbx3 prolonged the half-life of Meis1 by preventing its ubiquitination. Meis1 break-down could also be blocked by inhibition of the ubiquitin proteasome system, indicating tight post-transcriptional control. In addition, Meis1 and Pbx3 cooperated genetically as overexpression of Pbx3 induced endogenous Meis1 transcription. These functional interactions translated into in vivo activity. Blocking Meis1/Pbx3 dimerization abrogated the ability to enhance proliferation and colony-forming cell numbers in primary cells transformed by Hoxa9. Furthermore, expression of Meis1 target genes Flt3 and Trib2 was dependent on Pbx3/Meis1 dimerization. This correlated with the requirement of Meis1 to bind Pbx3 in order to form high affinity DNA/Hoxa9/Meis1/Pbx3 complexes in vitro. Finally, kinetics and severity of disease in transplantation assays indicated that Pbx3/Meis1 dimers are rate-limiting factors for Hoxa9-induced leukemia. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25911551      PMCID: PMC4486225          DOI: 10.3324/haematol.2015.124032

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  29 in total

1.  HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells.

Authors:  W F Shen; S Rozenfeld; A Kwong; L G Köm ves; H J Lawrence; C Largman
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  HOX genes regulate Rac1 activity in hematopoietic cells through control of Vav2 expression.

Authors:  C Breitinger; E Maethner; M-P Garcia-Cuellar; A Schambony; K D Fischer; K Schilling; R K Slany
Journal:  Leukemia       Date:  2012-06-20       Impact factor: 11.528

3.  Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL.

Authors:  C Lavau; S J Szilvassy; R Slany; M L Cleary
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

4.  Pbx modulation of Hox homeodomain amino-terminal arms establishes different DNA-binding specificities across the Hox locus.

Authors:  C P Chang; L Brocchieri; W F Shen; C Largman; M L Cleary
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

5.  Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b.

Authors:  E Kroon; J Krosl; U Thorsteinsdottir; S Baban; A M Buchberg; G Sauvageau
Journal:  EMBO J       Date:  1998-07-01       Impact factor: 11.598

6.  AbdB-like Hox proteins stabilize DNA binding by the Meis1 homeodomain proteins.

Authors:  W F Shen; J C Montgomery; S Rozenfeld; J J Moskow; H J Lawrence; A M Buchberg; C Largman
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

7.  An enhancer element in the EphA2 (Eck) gene sufficient for rhombomere-specific expression is activated by HOXA1 and HOXB1 homeobox proteins.

Authors:  J Chen; H E Ruley
Journal:  J Biol Chem       Date:  1998-09-18       Impact factor: 5.157

8.  Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia.

Authors:  U Thorsteinsdottir; E Kroon; L Jerome; F Blasi; G Sauvageau
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

9.  Identification of a new family of Pbx-related homeobox genes.

Authors:  T Nakamura; N A Jenkins; N G Copeland
Journal:  Oncogene       Date:  1996-11-21       Impact factor: 9.867

10.  Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias.

Authors:  T Nakamura; D A Largaespada; J D Shaughnessy; N A Jenkins; N G Copeland
Journal:  Nat Genet       Date:  1996-02       Impact factor: 38.330

View more
  28 in total

1.  RNA binding protein MSI2 positively regulates FLT3 expression in myeloid leukemia.

Authors:  Ayuna Hattori; Daniel McSkimming; Natarajan Kannan; Takahiro Ito
Journal:  Leuk Res       Date:  2017-01-11       Impact factor: 3.156

Review 2.  The molecular mechanics of mixed lineage leukemia.

Authors:  R K Slany
Journal:  Oncogene       Date:  2016-02-29       Impact factor: 9.867

3.  HoxA9 transforms murine myeloid cells by a feedback loop driving expression of key oncogenes and cell cycle control genes.

Authors:  Xiaoxia Zhong; Andreas Prinz; Julia Steger; Maria-Paz Garcia-Cuellar; Markus Radsak; Abderrazzak Bentaher; Robert K Slany
Journal:  Blood Adv       Date:  2018-11-27

4.  Transcription factor Meis1 act as a new regulator of ischemic arrhythmias in mice.

Authors:  Yining Liu; Jiamin Li; Ning Xu; Hang Yu; Liling Gong; Qingsui Li; Zhenyu Yang; Sijia Li; Jiming Yang; Di Huang; Yadong Xue; Genlong Xue; Jiali Liu; Haixin Chen; Ruijie Zhang; Anqi Li; Yiming Zhao; PengYu Li; Ming Li; Mingbin Liu; Ning Wang; Benzhi Cai
Journal:  J Adv Res       Date:  2021-11-15       Impact factor: 12.822

5.  Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist.

Authors:  Michael R McKeown; M Ryan Corces; Matthew L Eaton; Chris Fiore; Emily Lee; Jeremy T Lopez; Mei Wei Chen; Darren Smith; Steven M Chan; Julie L Koenig; Kathryn Austgen; Matthew G Guenther; David A Orlando; Jakob Lovén; Christian C Fritz; Ravindra Majeti
Journal:  Cancer Discov       Date:  2017-07-20       Impact factor: 39.397

6.  PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.

Authors:  Zejuan Li; Ping Chen; Rui Su; Chao Hu; Yuanyuan Li; Abdel G Elkahloun; Zhixiang Zuo; Sandeep Gurbuxani; Stephen Arnovitz; Hengyou Weng; Yungui Wang; Shenglai Li; Hao Huang; Mary Beth Neilly; Gang Greg Wang; Xi Jiang; Paul P Liu; Jie Jin; Jianjun Chen
Journal:  Cancer Res       Date:  2016-01-08       Impact factor: 12.701

Review 7.  Deregulation of the HOXA9/MEIS1 axis in acute leukemia.

Authors:  Cailin T Collins; Jay L Hess
Journal:  Curr Opin Hematol       Date:  2016-07       Impact factor: 3.284

8.  Dangerous liaisons: cooperation between Pbx3, Meis1 and Hoxa9 in leukemia.

Authors:  Ross M W Thorne; Thomas A Milne
Journal:  Haematologica       Date:  2015-07       Impact factor: 9.941

9.  LncRNA CD27-AS1 promotes acute myeloid leukemia progression through the miR-224-5p/PBX3 signaling circuit.

Authors:  Yanling Tao; Jingjing Zhang; Lulu Chen; Xin Liu; Mingkang Yao; Hao Zhang
Journal:  Cell Death Dis       Date:  2021-05-18       Impact factor: 8.469

10.  High expression of MAP7 predicts adverse prognosis in young patients with cytogenetically normal acute myeloid leukemia.

Authors:  Lin Fu; Huaping Fu; Lei Zhou; Keman Xu; Yifan Pang; Kai Hu; Jing Wang; Lei Tian; Yuanyuan Liu; Jijun Wang; Hongmei Jing; Wenrong Huang; Xiaoyan Ke; Jinlong Shi
Journal:  Sci Rep       Date:  2016-09-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.